Ryoichi Onozato

Activation of MET by Gene Amplification or by Splice Mutations Deleting the Juxtamembrane Domain in Primary Resected Lung Cancers

Ryoichi Onozato, Takayuki Kosaka, Hiroyuki Kuwano et al. · Journal of Thoracic Oncology · 2009 · 324 citations

Medicine, Molecular Biology, Oncology +15

Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma

Takayuki Kosaka, Yasushi Yatabe, Ryoichi Onozato et al. · Journal of Thoracic Oncology · 2009 · 261 citations · Full text

Medicine, Molecular Genetics, Oncology +15

Efficacy of Erlotinib for Brain and Leptomeningeal Metastases in Patients with Lung Adenocarcinoma Who Showed Initial Good Response to Gefitinib

Tatsuya Katayama, Junichi Shimizu, Kenichi Suda et al. · Journal of Thoracic Oncology · 2009 · 156 citations

Medicine, Oncology, Pharmacology +14

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers

Kenji Tomizawa, Kenichi Suda, Ryoichi Onozato et al. · Lung Cancer · 2011 · 148 citations

Medicine, Genetics, Oncology +13

SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non‐small cell lung cancer

Yoko Azuma, Takehiko Yokobori, Akira Mogi et al. · Journal of Surgical Oncology · 2015 · 80 citations

Medicine, Cancer Biology, Oncology +17